Surprisingly, tirzepatide shows slightly lower rates of nausea (30-37% vs 44%) and vomiting (9-17% vs 24%) in clinical trials despite being more potent
Watch it here: Full Measure: Pharma Ads Note: It is now (on October 6) 4 business days beyond the 15-day deadline for pharmaceutical companies to respond to the warning letters sent by the FDA regarding misleading and distracting drug advertising
Diabetics should monitor blood sugars closely when starting Saxenda, particularly if they use insulin or insulin secretagogues (e.g
Fitness professionals can use these research findings to share with their clients, when appropriate, to highlight the importance of exercise, especially strength training, while on and off GLP-1s
Retatrutide has been nicknamed Triple G
Tirzepatide is a GLP-1 and GIP receptor agonist that helps regulate appetite and blood sugar